Prevalence and Associated Factors of Uncorrected Refractive Error in Older Adults in a Population-Based Study in France.


Journal

JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539

Informations de publication

Date de publication:
01 01 2019
Historique:
pubmed: 17 10 2018
medline: 23 11 2019
entrez: 17 10 2018
Statut: ppublish

Résumé

Uncorrected refractive error (URE) is a common cause of visual impairment, but its prevalence in groups of older adults who could be pragmatic targets for improving optical correction remains unknown. To estimate the prevalence of URE in older adults, particularly in those with age-related eye disease and those who are unable to attend an outpatient clinic, and to identify the factors associated with URE. This population-based cross-sectional analysis included 707 adults 78 years or older from the Alienor Study in Bordeaux, France. Data were collected from February 12, 2011, through December 21, 2012, and analyzed from November 1, 2017, through July 7, 2018. Uncorrected refractive error was defined as the presenting distance visual acuity in the better-seeing eye improved by at least 5 letters on the Early Treatment Diabetic Retinopathy Study chart (≥1 line on the logMAR chart) using the best-achieved optical correction. Multivariate logistic regressions were used to determine the factors associated with URE. The study population of 707 adults 78 years or older (64.8% women; mean [SD] age, 84.3 [4.4] years) had a prevalence of URE of 38.8% (95% CI, 35.2%-42.5%). Prevalence was high for participants with eye disease (range, 35.0% [95% CI, 28.4%-42.0%] to 44.1% [95% CI, 27.2%-62.1%], depending on the disease) and those without eye disease (30.1%; 95% CI, 24.0%-36.7%). Prevalence was higher in participants who were examined at home (because they could not come to the clinic) than in those examined at the clinic (49.4% [95% CI, 42.8%-55.9%] vs 33.5% [95% CI, 29.2%-37.9%]; P < .001). Having an eye examination performed at home (odds ratio [OR], 1.64; 95% CI, 1.13-2.37), living alone (OR, 0.65; 95% CI, 0.47-0.90), and having the perceptions that the ophthalmologist consultation fees are too expensive (OR, 1.94; 95% CI, 1.12-3.36) and that declining visual acuity is normal with aging (OR, 1.47; 95% CI, 1.04-2.08) were all associated with URE. These study results show that the prevalence of URE was high in this population and suggest that preventive strategies aimed at enhancing optical correction could be directed to all older adults and to specific groups by implementing at-home eye examinations for those who have difficulties attending an outpatient clinic and by focusing on those with eye disease who probably already have a regular ophthalmologic follow-up. More studies are needed to evaluate prevalence of URE in different populations and countries with various eye care systems.

Identifiants

pubmed: 30326038
pii: 2703151
doi: 10.1001/jamaophthalmol.2018.4229
pmc: PMC6439784
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-11

Commentaires et corrections

Type : CommentIn

Références

Ophthalmic Physiol Opt. 2017 Mar;37(2):225-233
pubmed: 28211177
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3621-8
pubmed: 19264898
Lancet Glob Health. 2013 Dec;1(6):e339-49
pubmed: 25104599
Singapore Med J. 2012 Feb;53(2):82-7
pubmed: 22337179
BMC Med. 2014 Oct 31;12:192
pubmed: 25358236
Gerontologist. 1970 Spring;10(1):20-30
pubmed: 5420677
Clin Exp Ophthalmol. 2002 Jun;30(3):155-8
pubmed: 12010204
Ophthalmology. 2001 May;108(5):960-7
pubmed: 11320028
Ophthalmology. 1996 Mar;103(3):357-64
pubmed: 8600410
Br J Ophthalmol. 2002 Feb;86(2):238-42
pubmed: 11815354
Acta Ophthalmol. 2011 Nov;89(7):608-13
pubmed: 19925518
Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74
pubmed: 7604360
Neuroepidemiology. 2003 Nov-Dec;22(6):316-25
pubmed: 14598854
Public Health. 2015 Feb;129(2):110-6
pubmed: 25687709
Am J Ophthalmol. 2002 Nov;134(5):712-9
pubmed: 12429248
Ophthalmic Physiol Opt. 2014 Jan;34(1):38-45
pubmed: 24325433
Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2359-2365
pubmed: 28437525
Med J Aust. 1997 Jan 20;166(2):73-6
pubmed: 9033561
Am J Ophthalmol. 1999 May;127(5):590-6
pubmed: 10334353
Arch Ophthalmol. 1993 Jun;111(6):831-6
pubmed: 8512486
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Age Ageing. 2016 May;45(3):409-14
pubmed: 26946051
Optom Vis Sci. 2016 Mar;93(3):227-34
pubmed: 26905537
Br J Ophthalmol. 2012 Jul;96(7):991-6
pubmed: 22535330
Arch Ophthalmol. 1990 Feb;108(2):286-90
pubmed: 2271016
Br J Ophthalmol. 2002 Sep;86(9):1041-5
pubmed: 12185135
J Affect Disord. 2013 Oct;151(1):164-70
pubmed: 23787409
Am J Epidemiol. 2010 Mar 15;171(6):728-35
pubmed: 20150357
Acta Ophthalmol. 2008 Mar;86(2):196-201
pubmed: 17888085
Ophthalmic Epidemiol. 2013 Jun;20(3):123-30
pubmed: 23713914
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5264-73
pubmed: 18441303
Am J Public Health. 2017 Apr;107(4):564-569
pubmed: 28207341
J Nutr Health Aging. 2010 Dec;14(10):854-61
pubmed: 21125205
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Invest Ophthalmol Vis Sci. 2002 Mar;43(3):608-14
pubmed: 11867574
Surv Ophthalmol. 2010 Nov-Dec;55(6):539-60
pubmed: 20850856

Auteurs

Virginie Naël (V)

Institut National de la Santé et de la Recherche Medicale (INSERM), Bordeaux Population Health Research Center, Unité Mixte de Recherché 1219, University of Bordeaux, Bordeaux, France.
R&D Life and Vision Science, Essilor International, Paris, France.
Sorbonne University, INSERM, Centre National de la Recherche Scientifique, Institut de la Vision, Paris, France.

Gwendoline Moreau (G)

Institut National de la Santé et de la Recherche Medicale (INSERM), Bordeaux Population Health Research Center, Unité Mixte de Recherché 1219, University of Bordeaux, Bordeaux, France.

Solène Monfermé (S)

Institut National de la Santé et de la Recherche Medicale (INSERM), Bordeaux Population Health Research Center, Unité Mixte de Recherché 1219, University of Bordeaux, Bordeaux, France.

Audrey Cougnard-Grégoire (A)

Institut National de la Santé et de la Recherche Medicale (INSERM), Bordeaux Population Health Research Center, Unité Mixte de Recherché 1219, University of Bordeaux, Bordeaux, France.

Anne-Catherine Scherlen (AC)

R&D Life and Vision Science, Essilor International, Paris, France.

Angelo Arleo (A)

Sorbonne University, INSERM, Centre National de la Recherche Scientifique, Institut de la Vision, Paris, France.

Jean-François Korobelnik (JF)

Institut National de la Santé et de la Recherche Medicale (INSERM), Bordeaux Population Health Research Center, Unité Mixte de Recherché 1219, University of Bordeaux, Bordeaux, France.
Department of Ophthalmology, Bordeaux University Medical Center, Bordeaux, France.

Cécile Delcourt (C)

Institut National de la Santé et de la Recherche Medicale (INSERM), Bordeaux Population Health Research Center, Unité Mixte de Recherché 1219, University of Bordeaux, Bordeaux, France.

Catherine Helmer (C)

Institut National de la Santé et de la Recherche Medicale (INSERM), Bordeaux Population Health Research Center, Unité Mixte de Recherché 1219, University of Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH